Enhancing vaccine design strategies: applications for protein science, proteomics and adjuvants

Yvonne Perrie, Helen R. Griffiths, David Jones

Research output: Contribution to journalEditorial

Abstract

Vaccines have saved millions of lives. Currently, and for infectious diseases in humans at least, sanitation and vaccination remain the most efficient and the most cost- effective prophylactic treatment available. Vaccination has led to the global eradiation of smallpox, the virtual eradication of polio and a reduction of over 95% in the incidence of diphtheria, tetanus, pertussis, measles, mumps and rubella. [1] Indeed, successful vaccine strategies have circumvented mortality caused by infectious diseases in developed countries and have thus increased our lifespan. [1] Today’s society in developed countries has a life expectancy of more than 80 years, and there is a higher proportion of elderly to young people. However, there remains a continued need for the development of new vaccines to offer protection for infections where we currently have no effective vaccine (infections such as malaria or human immunodeficiency virus) and have recurrent diseases (such as tuberculosis, respiratory syncytial virus, influenza A and B), plus newly emergent diseases, such as West Nile fever or Ebola. Vaccination is also increasingly recognised as an important strategy for food security, by providing protection to livestock against existing and emerging pathogens.
LanguageEnglish
Pages287-289
Number of pages3
JournalJournal of Pharmacy and Pharmacology
Volume67
Issue number3
Early online date26 Mar 2015
DOIs
Publication statusPublished - 26 Mar 2015

Fingerprint

Proteomics
Vaccines
Vaccination
Developed Countries
Communicable Diseases
Proteins
West Nile Fever
Mumps
Smallpox
Sanitation
Diphtheria
Respiratory Syncytial Viruses
Food Supply
Rubella
Whooping Cough
Tetanus
Measles
Livestock
Poliomyelitis
Life Expectancy

Keywords

  • adjuvants, immunologic
  • biomedical research
  • biotechnology
  • humans
  • proteins
  • proteome
  • proteomics
  • science
  • vaccines

Cite this

@article{918c9fc8bde3439db43482a908089ab2,
title = "Enhancing vaccine design strategies: applications for protein science, proteomics and adjuvants",
abstract = "Vaccines have saved millions of lives. Currently, and for infectious diseases in humans at least, sanitation and vaccination remain the most efficient and the most cost- effective prophylactic treatment available. Vaccination has led to the global eradiation of smallpox, the virtual eradication of polio and a reduction of over 95{\%} in the incidence of diphtheria, tetanus, pertussis, measles, mumps and rubella. [1] Indeed, successful vaccine strategies have circumvented mortality caused by infectious diseases in developed countries and have thus increased our lifespan. [1] Today’s society in developed countries has a life expectancy of more than 80 years, and there is a higher proportion of elderly to young people. However, there remains a continued need for the development of new vaccines to offer protection for infections where we currently have no effective vaccine (infections such as malaria or human immunodeficiency virus) and have recurrent diseases (such as tuberculosis, respiratory syncytial virus, influenza A and B), plus newly emergent diseases, such as West Nile fever or Ebola. Vaccination is also increasingly recognised as an important strategy for food security, by providing protection to livestock against existing and emerging pathogens.",
keywords = "adjuvants, immunologic, biomedical research, biotechnology, humans, proteins, proteome, proteomics, science, vaccines",
author = "Yvonne Perrie and Griffiths, {Helen R.} and David Jones",
year = "2015",
month = "3",
day = "26",
doi = "10.1111/jphp.12414",
language = "English",
volume = "67",
pages = "287--289",
journal = "Journal of Pharmacy and Pharmacology",
issn = "0022-3573",
number = "3",

}

Enhancing vaccine design strategies : applications for protein science, proteomics and adjuvants. / Perrie, Yvonne; Griffiths, Helen R.; Jones, David.

In: Journal of Pharmacy and Pharmacology, Vol. 67, No. 3, 26.03.2015, p. 287-289.

Research output: Contribution to journalEditorial

TY - JOUR

T1 - Enhancing vaccine design strategies

T2 - Journal of Pharmacy and Pharmacology

AU - Perrie, Yvonne

AU - Griffiths, Helen R.

AU - Jones, David

PY - 2015/3/26

Y1 - 2015/3/26

N2 - Vaccines have saved millions of lives. Currently, and for infectious diseases in humans at least, sanitation and vaccination remain the most efficient and the most cost- effective prophylactic treatment available. Vaccination has led to the global eradiation of smallpox, the virtual eradication of polio and a reduction of over 95% in the incidence of diphtheria, tetanus, pertussis, measles, mumps and rubella. [1] Indeed, successful vaccine strategies have circumvented mortality caused by infectious diseases in developed countries and have thus increased our lifespan. [1] Today’s society in developed countries has a life expectancy of more than 80 years, and there is a higher proportion of elderly to young people. However, there remains a continued need for the development of new vaccines to offer protection for infections where we currently have no effective vaccine (infections such as malaria or human immunodeficiency virus) and have recurrent diseases (such as tuberculosis, respiratory syncytial virus, influenza A and B), plus newly emergent diseases, such as West Nile fever or Ebola. Vaccination is also increasingly recognised as an important strategy for food security, by providing protection to livestock against existing and emerging pathogens.

AB - Vaccines have saved millions of lives. Currently, and for infectious diseases in humans at least, sanitation and vaccination remain the most efficient and the most cost- effective prophylactic treatment available. Vaccination has led to the global eradiation of smallpox, the virtual eradication of polio and a reduction of over 95% in the incidence of diphtheria, tetanus, pertussis, measles, mumps and rubella. [1] Indeed, successful vaccine strategies have circumvented mortality caused by infectious diseases in developed countries and have thus increased our lifespan. [1] Today’s society in developed countries has a life expectancy of more than 80 years, and there is a higher proportion of elderly to young people. However, there remains a continued need for the development of new vaccines to offer protection for infections where we currently have no effective vaccine (infections such as malaria or human immunodeficiency virus) and have recurrent diseases (such as tuberculosis, respiratory syncytial virus, influenza A and B), plus newly emergent diseases, such as West Nile fever or Ebola. Vaccination is also increasingly recognised as an important strategy for food security, by providing protection to livestock against existing and emerging pathogens.

KW - adjuvants, immunologic

KW - biomedical research

KW - biotechnology

KW - humans

KW - proteins

KW - proteome

KW - proteomics

KW - science

KW - vaccines

U2 - 10.1111/jphp.12414

DO - 10.1111/jphp.12414

M3 - Editorial

VL - 67

SP - 287

EP - 289

JO - Journal of Pharmacy and Pharmacology

JF - Journal of Pharmacy and Pharmacology

SN - 0022-3573

IS - 3

ER -